EligibleTrials

Communication Bridge 3 Study

Recruiting · NCT06191198 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Chicago

View the official record on ClinicalTrials.gov →
Alzheimer's disease

Interventions studied

Communication Bridge™Evidence-Based Impairment Focused

What this trial is about

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Who can take part

Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.